Inspire Medical Systems Cash on Hand 2017-2025 | INSP

Inspire Medical Systems cash on hand from 2017 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Inspire Medical Systems Annual Cash on Hand
(Millions of US $)
2024 $446
2023 $460
2022 $451
2021 $214
2020 $234
2019 $149
2018 $188
2017 $16
2016 $0
Inspire Medical Systems Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $369
2024-12-31 $446
2024-09-30 $411
2024-06-30 $440
2024-03-31 $441
2023-12-31 $460
2023-09-30 $464
2023-06-30 $467
2023-03-31 $452
2022-12-31 $451
2022-09-30 $428
2022-06-30 $196
2022-03-31 $203
2021-12-31 $214
2021-09-30 $210
2021-06-30 $208
2021-03-31 $226
2020-12-31 $234
2020-09-30 $235
2020-06-30 $243
2020-03-31 $136
2019-12-31 $149
2019-09-30 $152
2019-06-30 $159
2019-03-31 $177
2018-12-31 $188
2018-09-30 $120
2018-06-30 $124
2018-03-31 $18
2017-12-31 $16
2017-09-30
2017-06-30
2017-03-31
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $4.033B $0.803B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.227B 59.07
Hims & Hers Health (HIMS) United States $12.367B 128.49
Tempus AI (TEM) United States $12.011B 0.00
IRhythm Technologies (IRTC) United States $4.742B 0.00
Hinge Health (HNGE) United States $2.855B 0.00
Privia Health (PRVA) United States $2.804B 191.67
Schrodinger (SDGR) United States $1.917B 0.00
Enovis (ENOV) United States $1.916B 10.69
Phreesia (PHR) United States $1.667B 0.00
Clover Health Investments (CLOV) United States $1.522B 0.00
Omnicell (OMCL) United States $1.463B 25.82
Azenta (AZTA) United States $1.393B 64.72
10x Genomics (TXG) United States $1.311B 0.00
Fulgent Genetics (FLGT) United States $0.663B 0.00
Butterfly Network (BFLY) United States $0.645B 0.00
Claritev (CTEV) United States $0.631B 0.00
Talkspace (TALK) United States $0.499B 149.00
Veradigm (MDRX) United States $0.476B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.372B 824.33
Outset Medical (OM) United States $0.366B 0.00
Health Catalyst (HCAT) United States $0.288B 0.00
Nyxoah SA (NYXH) Belgium $0.266B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.199B 0.00
KORU Medical Systems (KRMD) United States $0.148B 0.00
Pulmonx (LUNG) United States $0.137B 0.00
EUDA Health Holdings (EUDA) Singapore $0.124B 0.00
American Well (AMWL) United States $0.115B 0.00
MDxHealth SA (MDXH) Belgium $0.102B 0.00
CareCloud (CCLD) United States $0.094B 3.60
111 (YI) China $0.070B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.034B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.030B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
Precipio (PRPO) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.005B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00